FURNACE GREEN SURGERY
50 THE GLADE, FURNACE GREEN, CRAWLEY
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 26 | 30 | 86.7% | |
| HF 4 | 2011 | 34 | 40 | 85.0% | |
| HF 4 | 2012 | 39 | 43 | 90.7% | |
| HF 4 | 2013 | 37 | 40 | 92.5% | |
| HF004 | 2014 | 27 | 29 | 93.1% | |
| HF004 | 2015 | 24 | 25 | 96.0% | |
| HF004 | 2016 | 27 | 29 | 93.1% | |
| HF004 | 2017 | 27 | 31 | 87.1% | |
| HF004 | 2018 | 36 | 39 | 92.3% | |
| HF004 | 2019 | 33 | 34 | 97.1% | |
| HF004 | 2020 | 50 | 52 | 96.2% | |
| HF006 | 2021 | 66 | 66 | 100.0% | |
| HF006 | 2022 | 63 | 65 | 96.9% | |
| HF006 | 2023 | 68 | 68 | 100.0% |
